[The hepatic ChREBP expression and hyperinsulinemia in mice]

Area of Science:

• Metabolic Research
• Molecular Biology
• Endocrinology

Background:

• Hyperinsulinemia is associated with metabolic disorders.
• Carbohydrate response element-binding protein (ChREBP), acetyl-CoA carboxylase (ACC), and fatty acid synthase (FAS) are key regulators of lipid metabolism.
• Understanding the in vivo effects of insulin on these pathways is crucial.

Purpose of the Study:

• To investigate the impact of elevated serum insulin on hepatic ChREBP, ACC, and FAS expression in vivo.
• To determine if hyperinsulinemia, with or without hyperglycemia, contributes to glycolipid metabolic dysfunction.

Main Methods:

• Utilized KKAy mice (hyperinsulinemia and hyperglycemia) and Diet-Induced Obesity (DIO) mice (hyperinsulinemia only).
• Age-matched C57BL/6J mice served as controls.
• Quantified hepatic ChREBP, ACC, and FAS expression using Western blotting.
• Analyzed correlations between serum insulin, glucose, and triglyceride levels.

Main Results:

• KKAy mice showed significant positive correlations between serum insulin and glucose, and serum insulin and triglycerides.
• DIO mice exhibited a significant positive correlation between serum insulin and triglycerides.
• Hepatic expression of ChREBP, ACC, and FAS was significantly upregulated in both KKAy and DIO mice, correlating with hyperinsulinemia.

Conclusions:

• Hyperinsulinemia is a key driver of glycolipid metabolic disorders.
• Elevated insulin levels upregulate hepatic ChREBP expression, contributing to metabolic dysfunction.
• These findings highlight a potential mechanism linking hyperinsulinemia to dyslipidemia and metabolic syndrome.